| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Windtree Therapeutics Inc (NASDAQ: WINT)
WINT Technical Analysis
4
| As on 21st Feb 2025 WINT SHARE Price closed @ 4.35 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.93 & Strong Buy for SHORT-TERM with Stoploss of 1.07 we also expect STOCK to react on Following IMPORTANT LEVELS. |
WINTSHARE Price
| Open | 4.68 | Change | Price | % |
| High | 4.72 | 1 Day | 4.25 | 4250.00 |
| Low | 3.93 | 1 Week | 4.19 | 2618.75 |
| Close | 4.35 | 1 Month | 4.05 | 1350.00 |
| Volume | 293770 | 1 Year | 3.20 | 278.26 |
| 52 Week High 12.36 | 52 Week Low 0.10 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| UPC | 0.20 | 42.86% |
| ADTX | 0.09 | -25.00% |
| NVDA | 134.43 | -4.05% |
| LMDX | 0.02 | 0.00% |
| INTC | 24.87 | -4.68% |
| SMCI | 56.07 | -5.40% |
| AKTS | 0.04 | 0.00% |
| LCID | 3.06 | -7.55% |
| BHAT | 0.05 | -16.67% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| WINT Daily Charts |
WINT Intraday Charts |
Whats New @ Bazaartrend |
WINT Free Analysis |
|
|
WINT Important Levels Intraday
| RESISTANCE | 5.87 |
| RESISTANCE | 5.38 |
| RESISTANCE | 5.08 |
| RESISTANCE | 4.78 |
| SUPPORT | 3.92 |
| SUPPORT | 3.62 |
| SUPPORT | 3.32 |
| SUPPORT | 2.83 |
WINT Forecast February 2025
| 4th UP Forecast | 5.47 |
| 3rd UP Forecast | 5.11 |
| 2nd UP Forecast | 4.89 |
| 1st UP Forecast | 4.67 |
| 1st DOWN Forecast | 4.03 |
| 2nd DOWN Forecast | 3.81 |
| 3rd DOWN Forecast | 3.59 |
| 4th DOWN Forecast | 3.23 |
WINT Weekly Forecast
| 4th UP Forecast | 4.74 |
| 3rd UP Forecast | 4.61 |
| 2nd UP Forecast | 4.54 |
| 1st UP Forecast | 4.46 |
| 1st DOWN Forecast | 4.24 |
| 2nd DOWN Forecast | 4.16 |
| 3rd DOWN Forecast | 4.09 |
| 4th DOWN Forecast | 3.96 |
WINT Forecast2025
| 4th UP Forecast | 32.6 |
| 3rd UP Forecast | 23.54 |
| 2nd UP Forecast | 17.94 |
| 1st UP Forecast | 12.34 |
| 1st DOWN Forecast | -3.64 |
| 2nd DOWN Forecast | -9.24 |
| 3rd DOWN Forecast | -14.84 |
| 4th DOWN Forecast | -23.9 |
Windtree Therapeutics Inc ( NASDAQ USA Symbol : WINT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
WINT Business Profile
Windtree Therapeutics, Inc., a clinical-stage biotechnology and medical device company, focuses on the development of therapeutics for the treatment of acute pulmonary and cardiovascular diseases. Its lead development programs include istaroxime, which is in Phase 2b clinical trial for the treatment of acute decompensated heart failure, as well as in Phase 2a clinical trial for the treatment of early cardiogenic shock; AEROSURF, an aerosolized KL4 surfactant, which is in Phase 2b clinical trial to treat respiratory distress syndrome (RDS) in premature infants; lyophilized KL4 surfactant for the treatment of lung injury resulting from COVID-19; and Rostafuroxin that is in Phase 2b clinical trial for the treatment of genetically associated hypertension. The company has a collaboration with University of Milan-Bicocca for the discovery and development of new SERCA2a compounds for the treatment of chronic and acute human heart failure. The company was formerly known as Discovery Laboratories, Inc. and changed its name to Windtree Therapeutics, Inc. in April 2016. Windtree Therapeutics, Inc. was incorporated in 1992 and is headquartered in Warrington, Pennsylvania. Windtree Therapeutics, Inc. operates as a subsidiary of Lee's Pharmaceutical Holdings Limited. Address: 2600 Kelly Road, Warrington, PA, United States, 18976-3622
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service